Conmed (CNMD) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $49.24 -0.12%
Financial Fact:
Income from operations: 13.85M
Today's EPS Names:
TIC, ACFN, ATS, More
Financial Fact:
Income from operations: 13.85M
Today's EPS Names:
TIC, ACFN, ATS, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $274 million versus the consensus estimate of $278.76 million.
GUIDANCE:
Conmed sees FY2022 EPS of $3.60-$3.85, versus the consensus of $3.74. Conmed sees FY2022 revenue of $1.075-1.125 billion, versus the consensus of $1.11 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parker-Hannifin (PH) Tops Q4 EPS by 100c ; Offers Guidance
- Sionna Therapeutics (SION) Misses Q2 EPS by 14c
- Charles River Associates (CRAI) Tops Q2 EPS by 1c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
